NEW YORK, Feb. 9 /PRNewswire/ -- Small Bone Innovations, Inc. (SBi), a single-source provider of innovation, products, technology and education for the small bone & joint sector of the orthopedic industry, has announced that its Founder, Chairman & CEO, Anthony G. Viscogliosi, will be presenting at the First Albany Capital 2nd Annual Orthopedic conference on Tuesday, February 13, 2007, at 8:10 a.m. Pacific time. Mr. Viscogliosi will be available during a breakout session, immediately following his presentation, at 8:30 a.m. The conference is being held at the Marina Village Conference Center in San Diego, California.
Commenting on the First Albany Conference, Viscogliosi said, "Bill Plavonic and his team at First Albany Capital hosted a superb event last year in Chicago, which I was honored to be a part of, and judging from this year's line-up of impressive public and private presenting companies, it promises to be another tremendous event."
Viscogliosi added, "Small Bone Innovations had a record-setting year on many fronts in 2006. I look forward to sharing with the FAC attendees, the great strides we made to serve small bone & joint surgeons and their patients, as well as many of the exciting plans we have for 2007."
About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Bros., LLC, (VB), the New York-based merchant banking firm that specializes in the musculoskeletal/orthopedic sector. VB created SBi as the first company to focus purely on small bone & joint science. By integrating established companies and professionals in the field, SBi today offers a broad, clinically proven portfolio of innovation, products, technologies and education to treat trauma and diseases in small bones & joints.
In establishing SBi, VB acquired several prominent US, Canadian and European orthopedic device companies and product technology licenses focused on small bone and joint treatment, including arthroplasty, internal & external fixation, trauma, and tissue technology .
SBi completed a Series B financing, raising a record total of $42.2 million, announced in January, 2006. Based on data provided by Venture Source, this was the largest venture capital investment ever recorded in the field of orthopedic devices.
SBi was a 2006 recipient of Red Herring magazine's annual "Red Herring 100 North America" award, recognized as one of the nation's leading technology companies and the only orthopedic device company selected among an initial entry of more than one thousand firms.
Additionally, SBi's Artelon CMC-I Spacer, developed for patients with thumb base osteoarthritis, was featured on the cover and highlighted within Medical Design Technology magazine's "Year of Innovation" issue as one of the most fascinating technologies influencing the medical device industry.
For more information on SBi, please visit: www.totalsmallbone.com
Forward-looking statements
This press release may contain forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward- looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.
Small Bone Innovations, Inc.CONTACT: Anthony G. Viscogliosi, +1-212-583-9700 ext. 100, of Small BoneInnovations, Inc.; or Nick Kilsby, Creative Partners, +1-203-705-9202, forSmall Bone Innovations, Inc.
Web site: http://www.totalsmallbone.com/
